Verastem, Inc. — Form 8-K
Filed November 19, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
Verastem engaged Michael Bailey as a consultant effective November 17, 2026, to advise leadership on CEO transition. Bailey will receive $40,000/month ($80,000 total) for November–December 2026 as an independent contractor, with appointment as President and CEO effective January 1, 2027. The consulting agreement is a bridge arrangement with standard confidentiality, non-disclosure, and equity compliance provisions.
Why this rating
CEO transition is strategically significant for small-cap biotech ($254M mkt cap). Bailey's appointment signals leadership renewal and board confidence. $80K consulting fee is immaterial, but leadership change materially affects company trajectory and investor sentiment.
Tradability signal
NO TRADE
No trade: positive news with only -3.5% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.67% over 4 hrs, n=542). (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $6.86 ▲ 3.47% | at our read · unknown $6.63 | +10 min · unknown $6.66 ▲ 0.38% | +30 min · unknown $6.79 ▲ 2.34% | +1 hr · unknown $6.65 ▲ 0.30% | +4 hrs · unknown $6.54 ▼ 1.36% |
The stock had already moved -3.35% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.